Jiangxi Synergy Pharmaceutical Co., Ltd. (SHE:300636)
8.38
-0.04 (-0.48%)
Feb 27, 2026, 3:04 PM CST
SHE:300636 Revenue
Jiangxi Synergy Pharmaceutical had revenue of 208.82M CNY in the quarter ending September 30, 2025, with 11.14% growth. This brings the company's revenue in the last twelve months to 825.20M, up 12.67% year-over-year. In the year 2024, Jiangxi Synergy Pharmaceutical had annual revenue of 758.89M with 5.09% growth.
Revenue (ttm)
825.20M
Revenue Growth
+12.67%
P/S Ratio
4.26
Revenue / Employee
581.95K
Employees
1,418
Market Cap
3.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 758.89M | 36.75M | 5.09% |
| Dec 31, 2023 | 722.14M | 2.23M | 0.31% |
| Jan 1, 2023 | 719.91M | 127.78M | 21.58% |
| Dec 31, 2021 | 592.13M | 156.71M | 35.99% |
| Dec 31, 2020 | 435.42M | 22.36M | 5.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PKU HealthCare Corp.,Ltd. | 1.76B |
| Nanjing Well Pharmaceutical Group | 1.31B |
| Anhui Sunhere Pharmaceutical Excipients | 934.72M |
| Harbin Medisan Pharmaceutical | 874.60M |
| Zhejiang Shengda Bio-Pharm | 839.82M |
| Zhejiang Cheng Yi Pharmaceutical | 790.86M |
| Baotou Dongbao Bio-Tech Co.,Ltd | 784.62M |
| Tibet AIM Pharm. | 628.02M |